WO2004096124A3 - Compositions et procedes pour le diagnostic et le traitement de tumeurs - Google Patents
Compositions et procedes pour le diagnostic et le traitement de tumeurs Download PDFInfo
- Publication number
- WO2004096124A3 WO2004096124A3 PCT/US2003/009992 US0309992W WO2004096124A3 WO 2004096124 A3 WO2004096124 A3 WO 2004096124A3 US 0309992 W US0309992 W US 0309992W WO 2004096124 A3 WO2004096124 A3 WO 2004096124A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- tumor
- diagnosis
- treatment
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004571401A JP2007521791A (ja) | 2003-04-01 | 2003-04-01 | 腫瘍の診断と治療のための組成物と方法 |
CA002519241A CA2519241A1 (fr) | 2003-04-01 | 2003-04-01 | Compositions et procedes pour le diagnostic et le traitement de tumeurs |
AU2003237792A AU2003237792A1 (en) | 2003-04-01 | 2003-04-01 | Compositions and methods for the diagnosis and treatment of tumor |
PCT/US2003/009992 WO2004096124A2 (fr) | 2003-04-01 | 2003-04-01 | Compositions et procedes pour le diagnostic et le traitement de tumeurs |
EP03736450A EP1608967A4 (fr) | 2003-04-01 | 2003-04-01 | Compositions et procedes pour le diagnostic et le traitement de tumeurs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2003/009992 WO2004096124A2 (fr) | 2003-04-01 | 2003-04-01 | Compositions et procedes pour le diagnostic et le traitement de tumeurs |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004096124A2 WO2004096124A2 (fr) | 2004-11-11 |
WO2004096124A3 true WO2004096124A3 (fr) | 2004-12-29 |
Family
ID=33415184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/009992 WO2004096124A2 (fr) | 2003-04-01 | 2003-04-01 | Compositions et procedes pour le diagnostic et le traitement de tumeurs |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1608967A4 (fr) |
JP (1) | JP2007521791A (fr) |
AU (1) | AU2003237792A1 (fr) |
CA (1) | CA2519241A1 (fr) |
WO (1) | WO2004096124A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2994279A1 (fr) | 2015-08-04 | 2017-02-09 | Duke University | Polymeres discrets intrinsequement desordonnes codes genetiquement pour administration et leurs procedes d'utilisation |
US11752213B2 (en) | 2015-12-21 | 2023-09-12 | Duke University | Surfaces having reduced non-specific binding and antigenicity |
US11467156B2 (en) | 2016-06-01 | 2022-10-11 | Duke University | Nonfouling biosensors |
WO2018053201A1 (fr) | 2016-09-14 | 2018-03-22 | Duke University | Nanoparticules à base de polypeptide tribloc pour l'administration de médicaments hydrophiles |
KR20190064600A (ko) | 2016-09-23 | 2019-06-10 | 듀크 유니버시티 | Lcst 거동을 갖는 비구조화된 비-반복적 폴리펩티드 |
US11648200B2 (en) | 2017-01-12 | 2023-05-16 | Duke University | Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly |
US11554097B2 (en) | 2017-05-15 | 2023-01-17 | Duke University | Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents |
WO2019006374A1 (fr) | 2017-06-30 | 2019-01-03 | Duke University | Ordre et désordre en tant que principe de conception pour des réseaux de biopolymère sensibles à des stimuli |
CN110996967A (zh) | 2017-08-10 | 2020-04-10 | 华盛顿大学 | 使用烟酰胺单核苷酸进行治疗的组合物和方法 |
WO2019183476A1 (fr) * | 2018-03-23 | 2019-09-26 | Duke University | Conjugués biopolymère-immunotoxine à libération prolongée et leurs procédés d'utilisation |
WO2020028806A1 (fr) | 2018-08-02 | 2020-02-06 | Duke University | Protéines de fusion à double agoniste |
US11512314B2 (en) | 2019-07-12 | 2022-11-29 | Duke University | Amphiphilic polynucleotides |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002080842A2 (fr) * | 2001-04-05 | 2002-10-17 | Estetecon Ab | Medicament et procede de diagnostic d'un etat auto-immun |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
AU2353384A (en) | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
US4892538A (en) | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
US5283187A (en) | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
WO1991000360A1 (fr) | 1989-06-29 | 1991-01-10 | Medarex, Inc. | Reactifs bispecifiques pour le traitement du sida |
JPH05504553A (ja) | 1989-10-24 | 1993-07-15 | ギリアド サイエンシズ,インコーポレイテッド | 新規の結合を有するオリゴヌクレオチドアナログ |
US5602240A (en) | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
US5489677A (en) | 1990-07-27 | 1996-02-06 | Isis Pharmaceuticals, Inc. | Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms |
WO1992020373A1 (fr) | 1991-05-14 | 1992-11-26 | Repligen Corporation | Anticorps d'heteroconjugues pour le traitement des infections a l'hiv |
US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
US5719262A (en) | 1993-11-22 | 1998-02-17 | Buchardt, Deceased; Ole | Peptide nucleic acids having amino acid side chains |
US5714331A (en) | 1991-05-24 | 1998-02-03 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
AU4528493A (en) | 1992-06-04 | 1994-01-04 | Regents Of The University Of California, The | In vivo gene therapy with intron-free sequence of interest |
PT616812E (pt) | 1993-03-24 | 2000-04-28 | Berlex Biosciences | Combinacao de compostos anti-hormonais e moleculas de ligacao no tratamento do cancro |
US5910486A (en) | 1994-09-06 | 1999-06-08 | Uab Research Foundation | Methods for modulating protein function in cells using, intracellular antibody homologues |
US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
US5739277A (en) | 1995-04-14 | 1998-04-14 | Genentech Inc. | Altered polypeptides with increased half-life |
JP3756313B2 (ja) | 1997-03-07 | 2006-03-15 | 武 今西 | 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体 |
EP1557424A1 (fr) | 1997-09-12 | 2005-07-27 | Exiqon A/S | Dérivés de nucléosides, nucléotides et oligonucléotides bicycliques |
EP1463818A2 (fr) * | 2001-12-14 | 2004-10-06 | Incyte Genomics, Inc. | Transporteurs et canaux ioniques |
-
2003
- 2003-04-01 CA CA002519241A patent/CA2519241A1/fr not_active Abandoned
- 2003-04-01 AU AU2003237792A patent/AU2003237792A1/en not_active Abandoned
- 2003-04-01 WO PCT/US2003/009992 patent/WO2004096124A2/fr active Application Filing
- 2003-04-01 JP JP2004571401A patent/JP2007521791A/ja not_active Withdrawn
- 2003-04-01 EP EP03736450A patent/EP1608967A4/fr not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002080842A2 (fr) * | 2001-04-05 | 2002-10-17 | Estetecon Ab | Medicament et procede de diagnostic d'un etat auto-immun |
Non-Patent Citations (3)
Title |
---|
DATABASE GENBANK [online] 17 October 2002 (2002-10-17), SWANBECK G. ET AL.: "DNA encoding human autoimmune disease associated protein PAT1", XP002975783, Database accession no. ABX56570 * |
DATABASE GENBANK [online] 2 July 2002 (2002-07-02), HEWETT D.R. ET AL.: "Identification of a novel solute carrier (SLC12A8) within an area associated with psoriasis", XP002975782, Database accession no. AF390442 * |
See also references of EP1608967A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP1608967A4 (fr) | 2006-08-09 |
WO2004096124A2 (fr) | 2004-11-11 |
JP2007521791A (ja) | 2007-08-09 |
AU2003237792A8 (en) | 2004-11-23 |
AU2003237792A1 (en) | 2004-11-23 |
EP1608967A2 (fr) | 2005-12-28 |
CA2519241A1 (fr) | 2004-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003088808A3 (fr) | Compositions et methodes permettant de diagnostiquer et de traiter une tumeur | |
WO2006029183A3 (fr) | Compositions et procedes pour le diagnostic et le traitement d'une tumeur | |
WO2003024392A3 (fr) | Compositions et procedes pour le diagnostic et le traitement des tumeurs | |
WO2003000113A3 (fr) | Compositions et procedes destines au diagnostic et au traitement de tumeurs | |
WO2007001851A3 (fr) | Préparations et méthodes pour le diagnostic et le traitement d'une tumeur | |
EP1445317A3 (fr) | Compositions et procédés de diagnostic et traitement de tumeurs | |
WO2004112829A3 (fr) | Compositions et procedes pour le diagnostic et le traitement de tumeurs d'origine gliale | |
WO2006110760A3 (fr) | Compositions et methodes de diagnostic et de traitement de tumeur | |
MXPA05005107A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
EP2067472A8 (fr) | Compositions et procédés pour le traitement et le diagnostic d'une tumeur | |
EP1571968A3 (fr) | Compositions et methodes permettant de diagnostiquer et de traiter une tumeur | |
WO2004016225A8 (fr) | Compositions et methodes de diagnostic et de traitement des tumeurs | |
WO2005049075A3 (fr) | Compositions et methodes de traitement d'une tumeur d'origine hematopoietique | |
EP1572091A3 (fr) | Compositions et methodes de diagnostic et de traitement de tumeurs | |
WO2004060270A8 (fr) | Compositions et methodes pour diagnostiquer et traiter des tumeurs | |
WO2002016581A3 (fr) | Compositions et methodes pour le diagnostic et le traitement de tumeurs | |
WO2004024063A3 (fr) | Compositions et procede de diagnostic et de traitement des tumeurs | |
WO2005063299A3 (fr) | Compositions et methodes pour traitement des tumeurs d'origine hematopoietique | |
WO2002016602A3 (fr) | Compositions et procedes conçus pour le diagnostic et le traitement de tumeur | |
WO2005003154A8 (fr) | Compositions et methodes de diagnostic et de traitement de tumeur | |
WO2006014335A3 (fr) | Compositions et procedes pour le traitement de lymphome non hodgkinien | |
WO2004096124A3 (fr) | Compositions et procedes pour le diagnostic et le traitement de tumeurs | |
MXPA05008293A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
WO2006081272A3 (fr) | Compositions et methodes de diagnostic et de traitement d'une tumeur | |
WO2004019857A3 (fr) | Polypeptides de type achaete-scute 2 et acides nucleiques codants, methodes de diagnostic et de traitement des tumeurs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2519241 Country of ref document: CA Ref document number: 2003736450 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004571401 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003736450 Country of ref document: EP |